the Company is in discussions with each to determi
Post# of 151587
(Total Views: 468)
Posted On: 03/05/2021 8:26:54 PM
the Company is in discussions with each to determine the best path forward for approval of leronlimab for treatment of COVID-19 in critically ill population.>>
____________
OK. Keep discussing. In the meantime, sell all we have to any bidder who's happy with these results!
____________
OK. Keep discussing. In the meantime, sell all we have to any bidder who's happy with these results!
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼